X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4803) 4803
Book Review (582) 582
Publication (353) 353
Magazine Article (12) 12
Trade Publication Article (9) 9
Book / eBook (8) 8
Book Chapter (8) 8
Conference Proceeding (6) 6
Dissertation (2) 2
Microfilm (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4425) 4425
humans (3024) 3024
naphthalenes - therapeutic use (2531) 2531
male (2308) 2308
animals (1971) 1971
naphthalenes - pharmacology (1552) 1552
female (1468) 1468
pharmacology & pharmacy (1037) 1037
middle aged (912) 912
rats (887) 887
adult (859) 859
naphthalenes - administration & dosage (789) 789
antifungal agents - therapeutic use (776) 776
mice (632) 632
aged (593) 593
treatment outcome (559) 559
cinacalcet hydrochloride (538) 538
dose-response relationship, drug (518) 518
naphthalenes - adverse effects (489) 489
morpholines - pharmacology (450) 450
terbinafine (409) 409
dermatology (405) 405
neurosciences (379) 379
naphthalenes - chemistry (348) 348
administration, oral (344) 344
analysis (334) 334
onychomycosis - drug therapy (325) 325
urology & nephrology (323) 323
rats, sprague-dawley (316) 316
time factors (314) 314
antifungal agents - administration & dosage (295) 295
benzoxazines - pharmacology (293) 293
hyperparathyroidism, secondary - drug therapy (287) 287
adolescent (286) 286
naphthalene (262) 262
abridged index medicus (249) 249
secondary hyperparathyroidism (241) 241
itraconazole - therapeutic use (237) 237
disease models, animal (235) 235
double-blind method (227) 227
naphthalenes - pharmacokinetics (226) 226
biochemistry & molecular biology (223) 223
in vitro techniques (219) 219
chemistry, medicinal (218) 218
child (217) 217
drug therapy, combination (217) 217
rats, wistar (216) 216
cinacalcet (208) 208
naphthalenes - metabolism (206) 206
pyrazoles - pharmacology (206) 206
piperidines - pharmacology (205) 205
toxicology (204) 204
itraconazole (203) 203
parathyroid hormone - blood (202) 202
care and treatment (199) 199
clinical trials as topic (196) 196
administration, topical (190) 190
onychomycosis (189) 189
benzoxazines (188) 188
drug therapy (184) 184
adapalene (181) 181
dermatology & venereal diseases (179) 179
hyperparathyroidism, secondary - etiology (174) 174
cannabinoids - pharmacology (171) 171
calcium - blood (170) 170
therapy (169) 169
expression (167) 167
article (166) 166
research (165) 165
cell line, tumor (164) 164
activation (161) 161
structure-activity relationship (159) 159
double-blind (158) 158
cannabinoids (157) 157
naphthalenes (157) 157
kidney failure, chronic - complications (156) 156
enzyme inhibitors - pharmacology (151) 151
health aspects (150) 150
renal dialysis (149) 149
antifungal agents - adverse effects (148) 148
naphthalenes - toxicity (145) 145
cancer (144) 144
pharmacology (144) 144
antifungal agents - pharmacology (143) 143
drug interactions (143) 143
hyperparathyroidism (143) 143
follow-up studies (142) 142
calcium (141) 141
pharmacology/toxicology (141) 141
efficacy (140) 140
in-vitro (140) 140
foot dermatoses - drug therapy (137) 137
drug administration schedule (135) 135
prospective studies (135) 135
receptor, cannabinoid, cb1 - agonists (135) 135
morpholines - therapeutic use (134) 134
antifungal agents (133) 133
acne vulgaris - drug therapy (132) 132
young adult (132) 132
physiological aspects (131) 131
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4407) 4407
French (73) 73
German (70) 70
Japanese (68) 68
Russian (60) 60
Italian (50) 50
Spanish (37) 37
Chinese (17) 17
Polish (15) 15
Dutch (9) 9
Danish (6) 6
Portuguese (6) 6
Swedish (3) 3
Finnish (2) 2
Romanian (2) 2
Turkish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Czech (1) 1
Hebrew (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Cochrane database of systematic reviews, ISSN 1469-493X, 10/2018, Volume 10, Issue 10, pp. CD007360 - CD007360
Background Benign prostatic hyperplasia (BPH) is a common condition in ageing men that may cause lower urinary tract symptoms (LUTS). Treatment aims are to... 
Naphthalenes [adverse effects; therapeutic use] | 75 MG | EFFICACY | Prostatic Hyperplasia [complications] | STORAGE SYMPTOM | SEXUAL FUNCTION | CLINICAL PROGRESSION | Randomized Controlled Trials as Topic | MEDICINE, GENERAL & INTERNAL | OVERACTIVE BLADDER | Sulfonamides [adverse effects; therapeutic use] | Piperazines [adverse effects; therapeutic use] | ALPHA-ADRENOCEPTOR ANTAGONISTS | Adrenergic alpha-Antagonists [adverse effects; therapeutic use] | Prostatism [drug therapy; etiology] | TAMSULOSIN HYDROCHLORIDE | ALPHA-1 BLOCKERS | HEALTH-STATUS | Benzilates - adverse effects | Naphthalenes - adverse effects | Benzilates - therapeutic use | Humans | Adrenergic alpha-Antagonists - therapeutic use | Male | Prostatic Hyperplasia - complications | Prostatism - drug therapy | Urological Agents - adverse effects | Adrenergic alpha-Antagonists - adverse effects | Ethamsylate - therapeutic use | Lower Urinary Tract Symptoms - drug therapy | Lower Urinary Tract Symptoms - etiology | Ethamsylate - adverse effects | Urological Agents - therapeutic use | Prostatism - etiology | Tamsulosin - adverse effects | Tamsulosin - therapeutic use | Piperazines - therapeutic use | Piperazines - adverse effects | Indoles - adverse effects | Sulfonamides - therapeutic use | Quality of Life | Sulfonamides - adverse effects | Indoles - therapeutic use | Plant Extracts - therapeutic use | Drug Combinations | Naphthalenes - therapeutic use | Plant Extracts - adverse effects | Index Medicus
Journal Article
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 2015, Volume 10, Issue 1, pp. 98 - 109
Background and objectivesElevated parathyroid hormone levels may be associated with adverse clinical outcomes in patients on dialysis. After the introduction... 
ESRD | dialysis | parathyroid hormone | PERITONEAL-DIALYSIS | hyperparathyroidism | DIALYSIS PATIENTS | CLINICAL-PRACTICE GUIDELINE | CARDIOVASCULAR-DISEASE | MAINTENANCE HEMODIALYSIS | UROLOGY & NEPHROLOGY | PARATHYROID-HORMONE | MINERAL METABOLISM | RENAL REPLACEMENT | CHRONIC KIDNEY-DISEASE | CKD | PRACTICE PATTERNS | Hyperparathyroidism, Secondary - therapy | Up-Regulation | Naphthalenes - adverse effects | Prospective Studies | Parathyroidectomy - adverse effects | Humans | Middle Aged | Male | Parathyroid Hormone - blood | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Renal Insufficiency, Chronic - mortality | Adult | Female | Parathyroidectomy - mortality | Renal Insufficiency, Chronic - diagnosis | Dietary Supplements - adverse effects | Parathyroidectomy - trends | Risk Assessment | Risk Factors | Treatment Outcome | Biomarkers - blood | Calcimimetic Agents - adverse effects | Calcimimetic Agents - therapeutic use | Renal Insufficiency, Chronic - blood | Vitamin D - adverse effects | Hyperparathyroidism, Secondary - blood | Cinacalcet Hydrochloride | Hyperparathyroidism, Secondary - diagnosis | Hyperparathyroidism, Secondary - mortality | Renal Dialysis - adverse effects | Aged | Vitamin D - therapeutic use | Hyperparathyroidism, Secondary - etiology | Naphthalenes - therapeutic use | Index Medicus | Original
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 01/2016, Volume 173, Issue 1, pp. 77 - 87
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2012, Volume 37, Issue 11, pp. 1885 - 1895
Summary Background and aims Intestinal barrier impairment is incriminated in the pathophysiology of intestinal gut disorders associated with psychiatric... 
Endocrinology & Metabolism | Psychiatry | Lipopolysaccharide | HPA axis | Brain-gut interaction | Intestinal permeability | LIGHT-CHAIN KINASE | INDUCED VISCERAL HYPERSENSITIVITY | PSYCHIATRY | COLONIC RESPONSES | FECAL MICROBIOTA | BARRIER FUNCTION | ANXIETY-LIKE BEHAVIOR | NEUROSCIENCES | ENDOCRINOLOGY & METABOLISM | LACTOBACILLUS-FARCIMINIS TREATMENT | IRRITABLE-BOWEL-SYNDROME | VAGAL-AFFERENTS | Rats, Wistar | Colon - drug effects | Myosin-Light-Chain Kinase - antagonists & inhibitors | Corticotropin-Releasing Hormone - analysis | Inflammation - blood | Anti-Bacterial Agents - therapeutic use | Lipopolysaccharides - blood | Inflammation - metabolism | Inflammation - drug therapy | Stress, Psychological - metabolism | Female | Corticosterone - blood | Hypothalamo-Hypophyseal System - physiology | Adrenocorticotropic Hormone - blood | Pituitary-Adrenal System - physiology | Lactobacillus | Hypothalamo-Hypophyseal System - drug effects | Acute Disease | Permeability - drug effects | Restraint, Physical - psychology | Pituitary-Adrenal System - drug effects | Stress, Psychological - drug therapy | Rats | Colon - metabolism | Azepines - therapeutic use | Animals | Probiotics - therapeutic use | Cytokines - biosynthesis | Naphthalenes - therapeutic use | Prevention | Corticotropin releasing hormone | Gastrointestinal agents | Myosin | ACTH | Permeability | Stress (Psychology) | Muscle proteins | Index Medicus
Journal Article
Biomaterials, ISSN 0142-9612, 2015, Volume 60, pp. 130 - 140
Abstract Stem cell therapy has been proved to be an effective approach to ameliorate the heart remodeling post myocardial infarction (MI). However, poor cell... 
Advanced Basic Science | Dentistry | Myocardial infarction | Molecular imaging | Adipose-derived mesenchymal stem cells (AD-MSCs) | Angiogenesis | Hydrogel | Nitric oxide | SURVIVAL | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | REGENERATION | CARDIOMYOCYTES | CARDIAC REPAIR | DELIVERY | TRANSPLANTATION | S-NITROSYLATION | ENGRAFTMENT | CHITOSAN HYDROGEL | GROWTH-FACTOR | NIH 3T3 Cells | Optical Imaging | Galactose - metabolism | Hydrogel, Polyethylene Glycol Dimethacrylate - chemistry | Adipose Tissue - cytology | Delayed-Action Preparations - chemistry | Myocardial Infarction - therapy | Mesenchymal Stromal Cells - cytology | Ventricular Remodeling | Myocardial Infarction - pathology | beta-Galactosidase - metabolism | Nitric Oxide Donors - therapeutic use | Naphthalenes - metabolism | Oligopeptides - chemistry | Hydrogel, Polyethylene Glycol Dimethacrylate - metabolism | Naphthalenes - chemistry | Mice, Inbred C57BL | Cells, Cultured | Myocardium - pathology | Oligopeptides - metabolism | Delayed-Action Preparations - metabolism | Nitric Oxide Donors - administration & dosage | Galactose - chemistry | Animals | Heart - drug effects | Mice | Mesenchymal Stem Cell Transplantation | Neovascularization, Physiologic | Heart | Luciferase | Stem cells | Genetic engineering | Transplantation | Galactose | Vascular endothelial growth factor | Health aspects | Heart attack | Index Medicus | Biomedical materials | Effectiveness | Hydrogels | Migration | Mathematical models | Remodeling
Journal Article
Pain, ISSN 0304-3959, 11/2010, Volume 151, Issue 2, pp. 337 - 344
Cannabinoids are analgesic in man, but their use is limited by their psychoactive properties. One way to avoid cannabinoid receptor subtype 1 (CB1R)-mediated... 
Nociceptive flexor reflex | Analgesia | Cannabinoid receptor subtype 1 agonist | Rat | AZ11713908 | Peripheral site of action | EFFICACY | CUTANEOUS HYPERALGESIA | ALLODYNIA | RANDOMIZED CONTROLLED-TRIAL | NEUROSCIENCES | RAT MODEL | CLINICAL NEUROLOGY | STRATEGIES | ANTIHYPERALGESIC PROPERTIES | THERMAL NOCICEPTION | CB1 | ANESTHESIOLOGY | Inflammation - chemically induced | Humans | Calcium Channel Blockers - therapeutic use | Male | Naphthalenes - blood | Morpholines - blood | Dose-Response Relationship, Drug | Time Factors | Inflammation - drug therapy | Freund's Adjuvant - adverse effects | Neuralgia - chemically induced | Benzoxazines - blood | Carrageenan - adverse effects | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Disease Models, Animal | Mice, Inbred C57BL | Rats | Rats, Sprague-Dawley | Neuralgia - drug therapy | Benzoxazines - therapeutic use | Mice, Knockout | Receptor, Cannabinoid, CB1 - metabolism | Cannabinoids - therapeutic use | Pain Measurement - methods | Animals | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Mice | Receptor, Cannabinoid, CB1 - deficiency | Calcium Channel Blockers - blood | Naphthalenes - therapeutic use | Receptor, Cannabinoid, CB2 - deficiency | Models | Analgesics | Analysis | Chronic pain | Index Medicus
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 11/2013, Volume 720, Issue 1-3, pp. 247 - 254
The aim of this study was to determine the effect of WIN 55,212-2 mesylate (WIN – a non-selective cannabinoid CB and CB receptor agonist) on the protective... 
Antiepileptic drug | Maximal electroshock-induced seizure | Cannabinoid | WIN 55,212-2 mesylate | CB1 RECEPTOR AGONIST | CARBONIC-ANHYDRASE | GLUTAMATERGIC SYNAPTIC-TRANSMISSION | ACTIVATED CALCIUM-CHANNELS | RAT HIPPOCAMPAL-NEURONS | ADENOSINE RECEPTORS | CANNABINOID RECEPTOR | ANTI-CONVULSANT CARBAMAZEPINE | PHARMACOLOGY & PHARMACY | CORTICOSTRIATAL SYSTEM | ANTIEPILEPTIC DRUGS | Receptor, Cannabinoid, CB2 - agonists | Triazines - therapeutic use | Seizures - drug therapy | Male | Seizures - metabolism | Pregabalin | Brain - metabolism | Seizures - physiopathology | Drug Interactions | Receptor, Cannabinoid, CB1 - agonists | Cannabinoid Receptor Agonists - therapeutic use | gamma-Aminobutyric Acid - therapeutic use | Drug Therapy, Combination | Hand Strength | Morpholines - therapeutic use | gamma-Aminobutyric Acid - pharmacokinetics | Anticonvulsants - pharmacokinetics | Fructose - pharmacokinetics | Carbamazepine - analogs & derivatives | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Memory, Long-Term - drug effects | Fructose - therapeutic use | Benzoxazines - therapeutic use | Fructose - analogs & derivatives | Animals | Avoidance Learning - drug effects | Mice | Muscle Strength - drug effects | Carbamazepine - pharmacokinetics | gamma-Aminobutyric Acid - analogs & derivatives | Electroshock | Naphthalenes - therapeutic use | Seizures - psychology | Triazines - pharmacokinetics | Topiramate | Liquid chromatography | Seizures (Medicine) | Analysis | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9782, pp. 2013 - 2022
Journal Article